Autoimmune Diseases  >>  losmapimod (FTX-1821)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
losmapimod (FTX-1821) / Fulcrum Therap
NCT00517543: A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability

Completed
1
36
US
GW856553
GlaxoSmithKline
Chronic Obstructive Pulmonary Disease (COPD), Rheumatoid Arthritis, Atherosclerosis
10/07
10/07

Download Options